RxDoctor Payments Data

Eleanor Haring, PA

Physician Assistant · Glenwood Springs, CONPI 1447595913

Payments from drug & device makers

$2,110in general payments, 2019–2025

Across 91 payments — averaging $23.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$689
  • GSK$278
  • United Therapeutics Corporation$128
  • Boehringer Ingelheim$127
  • Actelion Pharmaceuticals US, Inc.$117
  • Takeda Pharmaceuticals U.S.A., Inc.$87
  • plus $685 from 16 others

What the payments were for

  • Food & beverage$2,110100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,110 in reported general payments places this provider in the 85th percentile of 2,849 physician assistant providers in Colorado.

See all physician assistant providers in Colorado

Medicare billing

Part B allowed, 2024
$66,758
Medicare patients
732
Services billed
799

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter78$100,130
Breztri AerosphereBudesonide/Glycopyr/Formoterol49$47,257
NucalaMepolizumab12$44,266
XareltoRivaroxaban35$42,269
EliquisApixaban36$36,570
Stiolto RespimatTiotropium Br/Olodaterol Hcl42$34,964
Spiriva RespimatTiotropium Bromide37$23,637
SymbicortBudesonide/Formoterol Fumarate70$23,437
Breo ElliptaFluticasone/Vilanterol31$21,747
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr20$21,080
Bevespi AerosphereGlycopyrrolate/Formoterol Fum17$16,783
Incruse ElliptaUmeclidinium Bromide23$16,384
DuleraMometasone/Formoterol11$6,666
Fluticasone-SalmeterolFluticasone Propion/Salmeterol41$5,259
Advair HfaFluticasone Propion/Salmeterol16$4,535

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Nucala, Breo Ellipta, Anoro Ellipta, Incruse Ellipta$278$203,608164 claims
AstraZenecaBreztri Aerosphere, Symbicort, Bevespi Aerosphere$689$87,477136 claims
Boehringer IngelheimStiolto Respimat, Spiriva Respimat$127$58,60179 claims
Johnson & JohnsonXarelto$76$42,26935 claims
MerckDulera$81$6,66611 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,849 physician assistant providers in Colorado.

Other physician assistant in Glenwood Springs

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →